Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 4 of 4 for “"GLP-1:glucagon"”.

  1. Cardiovascular Effects of GLP-1 and Glucagon Dual Receptor Agonism in Humans

    … including dipeptidyl peptidase IV inhibitors, glucagon like peptide-1 (GLP-1) receptor agonists and selective sodium-glucose transporter-2 inhibitors (SGLT2i). These medications have transformed treatment pathways and prognosis for individuals with T2DM as well as obesity (GLP-1 receptor …

    cambridge Repository record for Cardiovascular Effects of GLP-1 and Glucagon Dual Receptor Agonism in Humans (opens in a new tab)

  2. Butyrate-Induced Expression of Proglucagon: Implications for Enteroendocrine Signaling and Intestinal Growth

    … distal ileum and colon which expresses the proglucagon gene. Proglucagon encodes a number of important hormones, namely glucagon-like peptide 1 (GLP-1), glucagon-like peptide 2 (GLP-2), glicentin, and oxyntomodulin and thus may impact intestinal development and dysfunction, type 2 diabetes, and …

    uiuc Repository record for Butyrate-Induced Expression of Proglucagon: Implications for Enteroendocrine Signaling and Intestinal Growth (opens in a new tab)

  3. Butyrate-induced expression of proglucagon: implications for enteroendocrine signaling and intestinal growth

    … distal ileum and colon which expresses the proglucagon gene. Proglucagon encodes a number of important hormones, namely glucagon-like peptide 1 (GLP-1), glucagon-like peptide 2 (GLP-2), glicentin, and oxyntomodulin and thus may impact intestinal development and dysfunction, type 2 diabetes, and …

    uiuc Repository record for Butyrate-induced expression of proglucagon: implications for enteroendocrine signaling and intestinal growth (opens in a new tab)

  4. Butyrate-induced upregulation of intestinal glucose transport and signaling pathways represent a possible nutrient therapy for individuals with malabsorptive disorders

    … Dawley rat as an in vivo model. Finally, proglucagon mRNA, and the G-protein coupled receptors (GPCR), Free Fatty Acid Receptor FFAR2) and Free Fatty Acid Receptor 3 (FFAR3), were measured. To establish that butyrate increased the glucose transport capacity of the intestine through …

    uiuc Repository record for Butyrate-induced upregulation of intestinal glucose transport and signaling pathways represent a possible nutrient therapy for individuals with malabsorptive disorders (opens in a new tab)